X-49205282-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001256789.3(CACNA1F):​c.5756G>A​(p.Arg1919His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0882 in 1,206,688 control chromosomes in the GnomAD database, including 3,568 homozygotes. There are 36,726 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Synonymous variant affecting the same amino acid position (i.e. R1919R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.067 ( 252 hom., 2164 hem., cov: 22)
Exomes 𝑓: 0.090 ( 3316 hom. 34562 hem. )

Consequence

CACNA1F
NM_001256789.3 missense

Scores

2
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4O:1

Conservation

PhyloP100: 1.47

Publications

23 publications found
Variant links:
Genes affected
CACNA1F (HGNC:1393): (calcium voltage-gated channel subunit alpha1 F) This gene encodes a multipass transmembrane protein that functions as an alpha-1 subunit of the voltage-dependent calcium channel, which mediates the influx of calcium ions into the cell. The encoded protein forms a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Mutations in this gene can cause X-linked eye disorders, including congenital stationary night blindness type 2A, cone-rod dystropy, and Aland Island eye disease. Alternatively spliced transcript variants encoding multiple isoforms have been observed. [provided by RefSeq, Aug 2013]
CACNA1F Gene-Disease associations (from GenCC):
  • Aland island eye disease
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • inherited retinal dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • congenital stationary night blindness 2A
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • X-linked cone-rod dystrophy 3
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital stationary night blindness
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017129481).
BP6
Variant X-49205282-C-T is Benign according to our data. Variant chrX-49205282-C-T is described in CliVar as Benign. Clinvar id is 100576.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-49205282-C-T is described in CliVar as Benign. Clinvar id is 100576.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-49205282-C-T is described in CliVar as Benign. Clinvar id is 100576.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-49205282-C-T is described in CliVar as Benign. Clinvar id is 100576.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-49205282-C-T is described in CliVar as Benign. Clinvar id is 100576.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-49205282-C-T is described in CliVar as Benign. Clinvar id is 100576.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.205 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1FNM_001256789.3 linkc.5756G>A p.Arg1919His missense_variant Exon 48 of 48 ENST00000323022.10 NP_001243718.1 O60840-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1FENST00000323022.10 linkc.5756G>A p.Arg1919His missense_variant Exon 48 of 48 1 NM_001256789.3 ENSP00000321618.6 O60840-2
CACNA1FENST00000376265.2 linkc.5789G>A p.Arg1930His missense_variant Exon 48 of 48 1 ENSP00000365441.2 O60840-1
CACNA1FENST00000376251.5 linkc.5594G>A p.Arg1865His missense_variant Exon 48 of 48 1 ENSP00000365427.1 O60840-4

Frequencies

GnomAD3 genomes
AF:
0.0668
AC:
7369
AN:
110233
Hom.:
252
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0209
Gnomad AMI
AF:
0.00590
Gnomad AMR
AF:
0.0536
Gnomad ASJ
AF:
0.0782
Gnomad EAS
AF:
0.186
Gnomad SAS
AF:
0.221
Gnomad FIN
AF:
0.0744
Gnomad MID
AF:
0.0297
Gnomad NFE
AF:
0.0801
Gnomad OTH
AF:
0.0660
GnomAD2 exomes
AF:
0.0979
AC:
17653
AN:
180387
AF XY:
0.105
show subpopulations
Gnomad AFR exome
AF:
0.0193
Gnomad AMR exome
AF:
0.0680
Gnomad ASJ exome
AF:
0.0761
Gnomad EAS exome
AF:
0.188
Gnomad FIN exome
AF:
0.0826
Gnomad NFE exome
AF:
0.0811
Gnomad OTH exome
AF:
0.0843
GnomAD4 exome
AF:
0.0903
AC:
99025
AN:
1096402
Hom.:
3316
Cov.:
31
AF XY:
0.0955
AC XY:
34562
AN XY:
361860
show subpopulations
African (AFR)
AF:
0.0214
AC:
565
AN:
26383
American (AMR)
AF:
0.0659
AC:
2314
AN:
35105
Ashkenazi Jewish (ASJ)
AF:
0.0754
AC:
1459
AN:
19358
East Asian (EAS)
AF:
0.192
AC:
5790
AN:
30168
South Asian (SAS)
AF:
0.219
AC:
11843
AN:
53984
European-Finnish (FIN)
AF:
0.0831
AC:
3354
AN:
40381
Middle Eastern (MID)
AF:
0.0610
AC:
252
AN:
4133
European-Non Finnish (NFE)
AF:
0.0824
AC:
69316
AN:
840849
Other (OTH)
AF:
0.0897
AC:
4132
AN:
46041
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
3376
6752
10129
13505
16881
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2762
5524
8286
11048
13810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0668
AC:
7362
AN:
110286
Hom.:
252
Cov.:
22
AF XY:
0.0664
AC XY:
2164
AN XY:
32578
show subpopulations
African (AFR)
AF:
0.0208
AC:
633
AN:
30411
American (AMR)
AF:
0.0540
AC:
560
AN:
10365
Ashkenazi Jewish (ASJ)
AF:
0.0782
AC:
206
AN:
2635
East Asian (EAS)
AF:
0.185
AC:
631
AN:
3405
South Asian (SAS)
AF:
0.220
AC:
570
AN:
2592
European-Finnish (FIN)
AF:
0.0744
AC:
429
AN:
5769
Middle Eastern (MID)
AF:
0.0279
AC:
6
AN:
215
European-Non Finnish (NFE)
AF:
0.0801
AC:
4226
AN:
52727
Other (OTH)
AF:
0.0651
AC:
97
AN:
1489
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
233
465
698
930
1163
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0755
Hom.:
4779
Bravo
AF:
0.0614
TwinsUK
AF:
0.0790
AC:
293
ALSPAC
AF:
0.0848
AC:
245
ESP6500AA
AF:
0.0214
AC:
82
ESP6500EA
AF:
0.0846
AC:
569
ExAC
AF:
0.103
AC:
12483

ClinVar

Significance: Benign
Submissions summary: Benign:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3Other:1
May 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
NEI Ophthalmic Genomics Laboratory, National Institutes of Health
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.87
T
BayesDel_noAF
Benign
-0.87
CADD
Benign
10
DANN
Uncertain
0.99
DEOGEN2
Benign
0.051
.;.;T
FATHMM_MKL
Benign
0.33
N
LIST_S2
Uncertain
0.90
D;D;D
MetaRNN
Benign
0.0017
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.99
.;.;N
PhyloP100
1.5
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-0.23
N;N;N
REVEL
Benign
0.051
Sift
Benign
0.23
T;T;T
Sift4G
Benign
0.29
T;T;T
Polyphen
0.0010
.;.;B
Vest4
0.031
MPC
0.28
ClinPred
0.013
T
GERP RS
1.1
Varity_R
0.044
gMVP
0.65
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs33910054; hg19: chrX-49061742; COSMIC: COSV59904636; COSMIC: COSV59904636; API